Contact number
+1 617 526 6000Provided by WilmerHale
WilmerHale represents both issuers and investment banking firms in initial public offerings (IPOs), follow-on public offerings, PIPEs (private investments in public equity) and other private placements, cross-border offerings, Rule 144A offerings, and spin-off, carve-out and SPAC transactions. We are one of the world’s premier law firms for IPOs, and have led the eastern United States in handling IPOs—as both issuers' and underwriters' counsel—over the past 25 years. In 2020, we handled more than 75 public offerings and Rule 144A placements raising approximately $38 billion, for leading companies in life sciences, technology, financial services, communications and other industries. Since 2010, we have served as counsel in approximately 425 public offerings and Rule 144A placements with total proceeds in excess of $220 billion. Our clients range from emerging companies to established public companies and our lawyers understand the unique demands of complicated securities transactions across industries. We help our clients plan and complete the offering process effectively and efficiently, and no other firm is as well positioned to quickly grasp the subject matter and execute a deal that works from the start.
To learn more about WilmerHale's Capital Markets practice, visit: https://www.wilmerhale.com/en/solutions/capital-markets
Provided by Chambers
WilmerHale represented Solid BioSciences Inc., in its underwritten registered direct offerings of approximately $200 million.
Provided by Chambers
WilmerHale has a large team with significant public company and life sciences experience.
They are practical from a legal risk perspective and are able to manage matters efficiently.
WilmerHale works collaboratively to deliver a high level of client service.
WilmerHale has a large team with significant public company and life sciences experience.
They are practical from a legal risk perspective and are able to manage matters efficiently.
WilmerHale works collaboratively to deliver a high level of client service.
Provided by Chambers
Cynthia Mazareas represents clients from the life sciences sector in a range of capital market transactions, including public and private offerings, venture capital financings and regulatory compliance.
Cynthia has sharp analytical skills. We rely on her for her strategic advice.
Cynthia is thoughtful, responsive and practical in her advice.
Molly Fox is notable for her public offerings and public company representation. She represents a wide range of life sciences and technology companies in equity and debt capital market matters.
Molly is able to marshal team and provide seamless transactional support to complete time pressured matters successfully.
Molly always provides practical and sophisticated advice.
Stuart Falber is co-chair of the WilmerHale life sciences group. He is known for his representation of life science clients. He has notable experience in public offerings.